United-Guardian, Inc. (UG)
- Previous Close
8.20 - Open
8.12 - Bid --
- Ask 9.68 x 100
- Day's Range
8.12 - 8.19 - 52 Week Range
7.73 - 16.25 - Volume
3,794 - Avg. Volume
8,803 - Market Cap (intraday)
37.352M - Beta (5Y Monthly) 0.92
- PE Ratio (TTM)
12.90 - EPS (TTM)
0.63 - Earnings Date Aug 7, 2025 - Aug 11, 2025
- Forward Dividend & Yield 0.70 (8.61%)
- Ex-Dividend Date Feb 10, 2025
- 1y Target Est
--
United-Guardian, Inc. develops, manufactures, sells, and markets specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL, a line of multifunctional hydrogel formulations for personal care and medical products; B-122, a powdered lubricant used in the manufacture of certain cosmetics, such as pressed powders, eyeliners, and rouges, as well as some industrial products; ORCHID COMPLEX, an oil-based extract of orchids; and LUBRASIL II SB, a special formulation of Lubrajel in which silicone oil is incorporated into a Lubrajel base. It also provides medical lubricant products for catheter lubrication, medical devices, condom lubrication, and oral care under the Lubrajel brand, including Lubrajel MG, Lubrajel MGL, Lubrajel RRCG, Lubrajel RR, Lubrajel RC, Lubrajel RA, Lubrajel Fluid, Lubrajel LC, Lubrajel BA, and Lubrajel FACO. In addition, the company offers pharmaceutical products comprising RENACIDIN, a prescription to prevent and to dissolve calcifications in urethral catheters; and CLORPACTIN WCS-90, a chlorine-based drug, which is a topical antimicrobial and is also used in urology. Further, it provides sexual wellness ingredient products, which are hydrogel formulations designed to offer sensory enhancement, lubrication, and moisturization, such as Natrajel NT, Natrajel MA, Natrajel ON, and Natrajel TE product lines. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.
u-g.com24
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: UG
View MorePerformance Overview: UG
Trailing total returns as of 6/13/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: UG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: UG
View MoreValuation Measures
Market Cap
37.35M
Enterprise Value
29.23M
Trailing P/E
12.90
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.27
Price/Book (mrq)
3.45
Enterprise Value/Revenue
2.56
Enterprise Value/EBITDA
8.78
Financial Highlights
Profitability and Income Statement
Profit Margin
25.30%
Return on Assets (ttm)
15.65%
Return on Equity (ttm)
26.24%
Revenue (ttm)
11.41M
Net Income Avi to Common (ttm)
2.89M
Diluted EPS (ttm)
0.63
Balance Sheet and Cash Flow
Total Cash (mrq)
8.12M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
2.02M